scholarly journals Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years

2020 ◽  
Vol 43 ◽  
pp. 102146 ◽  
Author(s):  
Jiwon Oh ◽  
Anat Achiron ◽  
Elisabeth G. Celius ◽  
Christina Chambers ◽  
Joy Derwenskus ◽  
...  
Keyword(s):  
Pregnancy Outcomes ◽  
Development Program ◽  
Clinical Development ◽  
Phase 2 ◽  
Clinical Development Program ◽  
Relapse Rates

Pregnancy Outcomes in Women Exposed to Ustekinumab in the Crohnʼs Disease Clinical Development Program

2018 ◽  
Vol 113 ◽  
pp. S4 ◽  
Author(s):  
Scherl Ellen ◽  
Jacobstein Douglas ◽  
Murphy Conor ◽  
Ott Elyssa ◽  
Gasink Christopher ◽  
...  
Keyword(s):  
Pregnancy Outcomes ◽  
Development Program ◽  
Clinical Development ◽  
Clinical Development Program

scholarly journals Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

Neurology ◽  
2014 ◽  
Vol 82 (8) ◽  
pp. 674-680 ◽  
Author(s):  
G. Karlsson ◽  
G. Francis ◽  
G. Koren ◽  
P. Heining ◽  
X. Zhang ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Pregnancy Outcomes ◽  
Development Program ◽  
Clinical Development ◽  
Clinical Development Program

scholarly journals Dalbavancin safety in the phase 2/3 clinical development program

Critical Care ◽  
2008 ◽  
Vol 12 (Suppl 2) ◽  
pp. P27
Author(s):  
E Seltzer ◽  
L Goldberg ◽  
D Krause ◽  
D Simoneau ◽  
E Boudry
Keyword(s):  
Development Program ◽  
Clinical Development ◽  
Phase 2 ◽  
Clinical Development Program
Sign in / Sign up

Export Citation Format

Share Document